Armenia State Duty Law and Medical Device Registration Fees

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

The state duties (State Duty) related to medical device registration are set by each member state: Article 3 of Decision No. 46 requires member states to approve the fee amounts by 31 December 2016, and Article 15 provides that the costs are borne by the applicant under member state legislation. The GRZAN conclusion: the specific amounts on the Armenian side are determined under the Law of the Republic of Armenia on State Duty; any amount that cannot be verified against official texts must be listed as a practical estimate, and unverified figures must never be cited. Budgets should be calculated in three segments: reference-state fees, recognition-state coordination fees, and change or reissuance fees. Blending all fee types into a single lump-sum figure is the most common budgeting mistake observed in registration projects.

2. Legal basis

RegulationReference numberPublication date (effective date)Provision
Rules for the Registration and Expert Review of Medical Devices for Safety, Quality and EffectivenessEurasian Economic Commission Council Decision No. 46 of 2016-02-12Amended by Council Decision No. 144 of 2021-12-24Article 3, item a; Article 15
Law of the Republic of Armenia on State Duty——Provisions on registration-related duties
Official page of the Ministry of Health of Armenia (State Registration of Medical Devices)—CurrentExplanation on state duties
Requirements for the Implementation, Maintenance and Evaluation of Quality Management Systems for Medical Devices According to Potential Use RisksEurasian Economic Commission Council Decision No. 106 of 2017-11-10Amended by Council Decision No. 43 of 2026-04-27Inspection-related procedures

3. Expert insights

Insight 1: Article 3, item a is the legal source for fee setting and expressly requires grading by complexity and workload. The provision requires member states to approve, by 2016-12-31, the amounts of the duties (taxes) or other mandatory payments provided for in the Rules, taking into account the complexity of the procedures and the scope of work performed in the reference state and the recognizing state, covering: first, registration of medical devices; second, expert review of the safety, quality and effectiveness of medical devices; third, changes to the registration dossier of a medical device; fourth, reissuance of the registration certificate. GRZAN note: this shows that the fees are not a single rate but are tiered by procedure type, and that the reference state and the recognizing state each charge separately.

Insight 2: Article 3, item b requires member states to designate competent bodies and notify the Commission. The same provision requires member states to identify the bodies (organizations) responsible for registration, changes to the registration dossier and other related procedures under the Rules, and to notify the Eurasian Economic Commission accordingly. GRZAN note: on the Armenian side, the registration function rests with the Ministry of Health and the identification function with the Scientific Center of Drug and Medical Technology Expertise (SCDMTE), per Government Decision No. 1795-Ն of 2022-11-24.

Insight 3: Article 15 locks the cost burden onto the applicant. The provision states that the costs arising from registration and expert review procedures, coordination of expert opinions, changes to the registration dossier (including the notification procedure), reissuance of the registration certificate, or coordination of expert opinions on registered medical devices are borne by the applicant under member state legislation. GRZAN note: the statutory bearer of the costs is the applicant, meaning the manufacturer or its authorized representative; advance payment arrangements between the representative and the manufacturer are an internal allocation and do not change who is liable toward the competent authority.

Insight 4: The timing of payment affects the progress of the procedure. Under Article 14, item a of Decision No. 46, where the authorized body (expert organization) of the reference state requests a copy of the payment receipt for the coordination procedure in the recognizing state, the period from the dispatch of the request to the receipt of the response is not counted in the authority’s clock. GRZAN note: this means payment of the recognizing-state fee is a precondition for the procedure to advance; failure to pay in time directly stops the clock (practical estimate: the specific payment deadline is subject to the notice of the competent authority).

Insight 5: A three-segment budget composition (GRZAN method).

SegmentFee typeLegal sourceEstimation point
Segment 1Reference-state registration and expert review feesDecision No. 46, Article 3, item a, first and second itemsTiered by risk class and procedural complexity
Segment 2Recognition-state expert opinion coordination feesDecision No. 46, Article 3, item a (scope of work in reference and recognizing states)Counted per recognizing state, each listed separately
Segment 3Change and reissuance feesDecision No. 46, Article 3, item a, third and fourth itemsReserved per expected change frequency
SeparateManufacturing inspection costsDecision No. 106 frameworkCharged by the inspection organization under contract (practical estimate)
SeparateTesting costsDecisions No. 28, 38 and 29Charged by accredited testing laboratories under contract (practical estimate)

4. Practical recommendations

  1. Never cite unverified amounts: every fee statement in external materials must be traceable to the current text of the Law on State Duty or a published tariff of the competent authority; where it cannot be verified, mark it as a practical estimate.
  2. Estimate the three segments separately: list reference-state, recognizing-state and change or reissuance costs separately instead of estimating with a single figure.
  3. Reserve a currency buffer: duties are payable in Armenian drams, so reserve a buffer for exchange-rate movement and bank charges in the budget (practical estimate).
  4. Manage payment receipts in the workflow: the payment receipt is a required document for acceptance and for advancing the coordination procedure; archive it together with the application form.
  5. Agree on advance payment in the authorization: in the power of attorney or service agreement, state who advances the duties, the settlement cycle and how receipts are handed over.

5. Verification checklist

  1. □ The legal sources of the fees, Article 3, item a and Article 15 of Decision No. 46, have been confirmed.
  2. □ The applicable rates have been checked against the current text of the Law of the Republic of Armenia on State Duty (unverifiable items marked as practical estimate).
  3. □ The budget has been estimated separately for the reference state, recognizing states and changes or reissuance.
  4. □ A buffer for exchange-rate movement and bank charges has been reserved.
  5. □ A synchronized archiving process for payment receipts has been established.
  6. □ The advance payment and settlement mechanism for duties has been agreed in the power of attorney or service agreement.
  7. □ It has been confirmed that inspection and testing costs are governed by separate contracts and not mixed into the duty budget.

Regulatory information verified as of October 30, 2026.

This guide was prepared and translated by GRZAN. GRZAN provides end-to-end regulatory services for medical device manufacturers entering Armenia and the Eurasian Economic Union, including registration, fee budgeting, authorized representative services and quality management system consulting. For tailored advice on license-holder, import and fee matters, contact info@grzanglobal.com.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail